(NRC) National Research - Ratings and Ratios

National Research Corporation is a healthcare analytics firm that provides critical insights to healthcare organizations, enabling them to enhance patient and employee experiences. By leveraging its suite of subscription-based solutions, healthcare providers can access actionable data and analysis on various aspects, including patient satisfaction, employee engagement, and reputation management. The companys innovative solutions, such as Huey AI, a cutting-edge AI engine, empower healthcare organizations to make informed decisions and drive meaningful improvements.

The companys diverse portfolio includes marketing experience solutions, experience solutions, reputation solutions, employee experience solutions, and consumer experience solutions, all designed to help healthcare organizations navigate the complex landscape of modern healthcare. With a strong foundation established in 1981, National Research Corporation has evolved to meet the changing needs of the healthcare industry, providing a comprehensive range of tools and services to its clients.

Analyzing the provided and , we can observe that National Research Corporations stock has experienced significant fluctuations, with a 52-week high of $31.03 and a low of $10.13. The current price of $12.99 is near the SMA50, indicating a potential support level. However, the SMA200 at $17.64 suggests that the stock has been trending downward in the long term. The P/E ratio of 12.52 and RoE of 71.32 indicate that the company is relatively undervalued and has a strong return on equity.

Based on the available data, a forecast for National Research Corporation can be constructed. Given the current prices proximity to the SMA50 and the relatively low ATR of 0.86 (6.63%), it is likely that the stock will experience a period of consolidation or slight upward movement in the near term. However, the long-term trend indicated by the SMA200 suggests that the stock may face challenges in sustaining a significant upward trend. Therefore, a potential trading strategy could involve buying the stock at the current price, with a target price around $15-$16, and a stop-loss around $11.50. A thorough risk assessment and continuous monitoring of the stocks performance are essential to adjust the strategy accordingly.